Wells Fargo analyst Brandon Couillard lowered the firm’s price target on Thermo Fisher (TMO) to $565 from $570 and keeps an Overweight rating on the shares. Aside from a solid Q2 beat/raise, the firm is encouraged that Thermo Fisher addressed the elephant in the room by pointing to realistic +3%-6% core growth expectations in 2026/2027 and an updated LRP, but with higher margin exp goals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher Scientific Reports Steady Q2 2025 Growth
- Thermo Fisher’s Earnings Call Highlights Growth and Challenges
- Thermo Fisher’s Strong Q2 Performance and Strategic Forecast Adjustments Justify Buy Rating
- Thermo Fisher Announces CFO Retirement and Successor
- Thermo Fisher’s Strong Performance and Promising Growth Prospects Earns Buy Rating from Analyst Vijay Kumar